<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05619588</url>
  </required_header>
  <id_info>
    <org_study_id>CR16-002</org_study_id>
    <nct_id>NCT05619588</nct_id>
  </id_info>
  <brief_title>Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only</brief_title>
  <official_title>An Open Label, Multi-Center, Single Arm Prospective Evaluation of Exactech Vantage Total Ankle System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Exactech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Exactech</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to evaluate the performance and safety of the Vantage Total&#xD;
      Ankle System. This study will follow subjects for a period of up to 10 years post-surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 4, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2031</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AOFAS</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>American Orthopedic Foot and Ankle Society Score (AOFAS) - Questionaire on pain (40 points), function (45 points) , and alignment (15 points) - 100 points score where 100 indicates a healthy midfoot</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SMFA</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Short Musculoskeletal Function Assessment (SMFA) Score - 46 items Patient questionnaire divided into two sections: 34 questions on patients function assessment and 12 questions covering how bothered patients are by their symptoms where 1 indicates no problems/no difficulty/ not bothered and 5 indicates unable to do/symptoms all the time/being greatly bothered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SF-36</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Short Form Health Survey (SF-36) Score - 36-item patient-reproted survey of patient health - It consists on 8 scales: Physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. Each scale is transformed into a 0-100 scale where the lower score indicates the more disability and the higher score the lest disability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sports Frequency Score</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Sports Frequency Score - Level of sport activity in leisure time where 0 indicates &quot;no sports activity&quot; and 4 indicates &quot;professional level of sports activity, elite athlete</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VAS Pain and Patient Satisfaction Score</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Visual Analog Scale (VAS) Score - Range of scores from 0-100 to indicate level of pain - Higher score indicates greater pain intensity</description>
  </primary_outcome>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Ankle Rheumatoid Arthritis</condition>
  <condition>Arthritis of Ankle</condition>
  <condition>Failure, Prosthesis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who meet eligibility criteria - Patients who consent to participate to return for&#xD;
        follow-up visits out to 10 years or longer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is indicated for total ankle arthroplasty&#xD;
&#xD;
          -  Patient is skeletally mature&#xD;
&#xD;
          -  Patient is mentally capable of completing follow-up forms&#xD;
&#xD;
          -  Patient will be available for follow-up out to 10 years&#xD;
&#xD;
          -  Patient has been deemed a candidate for Ankle replacement by diagnosis of the&#xD;
             investigator&#xD;
&#xD;
          -  Patient is willing and able to read and sign a study informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with excessive bone loss at the ankle joint site&#xD;
&#xD;
          -  Patient with severe osteoporosis&#xD;
&#xD;
          -  Patient with complete talar avascular necrosis&#xD;
&#xD;
          -  Patient with Active Osteomyelitis&#xD;
&#xD;
          -  Patient with Infection at the ankle site or infection at distant sites that could&#xD;
             migrate to the ankle&#xD;
&#xD;
          -  Patient with Sepsis&#xD;
&#xD;
          -  Patient with Vascular deficiency in the involved limb&#xD;
&#xD;
          -  Patient with Neuromuscular inadequacy (e.g. Prior paralysis, fusion and or inadequate&#xD;
             abductor strength)&#xD;
&#xD;
          -  Patient with Neuropathic joints&#xD;
&#xD;
          -  Patient with Neurological or musculoskeletal disease or loss of function that may&#xD;
             adversely affect movement of the lower limb, gait, or weight bearing&#xD;
&#xD;
          -  Patient with Poor soft tissue coverage around the ankle&#xD;
&#xD;
          -  Patient with Charcot arthropathy&#xD;
&#xD;
          -  Previous ankle arthrodesis with excision of the malleoli&#xD;
&#xD;
          -  Excessive loads as caused by activity or patient weight - per investigator discretion&#xD;
&#xD;
          -  Skeletally immature patients (patient is less than 21 years if age at time of surgery)&#xD;
&#xD;
          -  Patient with dementia&#xD;
&#xD;
          -  Patient with known metal allergies&#xD;
&#xD;
          -  Patient who is pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rachael Craig</last_name>
    <phone>352-377-1140</phone>
    <email>rachael.craig@exac.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandrine Angibaud</last_name>
    <phone>352-377-1140</phone>
    <email>sandrine.angibaud@exac.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Roberston</last_name>
      <phone>919-584-9493</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>November 16, 2022</last_update_submitted>
  <last_update_submitted_qc>November 16, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

